Clondalkin Group Reports Alliance with Pharma Prospect
- Published: February 13, 2014
AMSTERDAM, THE NETHERLANDS | Clondalkin Group, the international producer of high value-added packaging solutions, has joined forces with print manufacturer Pharma Prospect, Barcelona, Spain, in a strategic alliance to develop and strengthen its pharma and healthcare business across Europe. The associate marketing agreement will allow Clondalkin Group to further strengthen its growing pharma and healthcare business by widening its customer portfolio across Europe.
Pharma Prospect manufactures a full range of printed paper leaflets that are supported by extensive design, prepress, supply chain management, and packaging system services.
Clondalkin Group Pharma & Healthcare division is a global supplier of cartons, labels, and literature and operates 17 accredited pharma and healthcare sites throughout North America and Europe, including a carton operation in Spain formerly known as Cartonplex, which is also based in Barcelona.
Malcolm Farnan, sales and marketing director of Clondalkin Group, says, "We are very pleased to form this strategic alliance. Pharma Prospect specializes in the manufacture of print solutions to some of the world's leading manufacturers in the pharmaceutical, medical device, healthcare, and cosmetic industries and complements our own capabilities perfectly. Like us, they focus on providing innovative, value-added packaging solutions and developing strong and long-lasting customer relationships. By working together and effectively promoting each other's skills and expertise, the agreement will enable both parties to realize new opportunities and strengthen our growth strategies in Europe.”
Tony Pirretas, director general at Pharma Prospect, says, "This agreement will enable us to build a strong team in the Spanish pharmaceutical market. It will strengthen our credibility and demonstrate to our customers our commitment to become a market-leading global packaging supplier."
